Menoria, Marcela T.
HRN: 10-63-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2023
METRONIDAZOLE 500MG (TAB)
05/24/2023
06/06/2023
ORAL
500mg/cap
BID
H. Pylori
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes